Coca-Cola Stock Is Crushing the Market This Year. Is It Time to Buy?

Coca-Cola delivered 5% organic revenue growth year-over-year in both Q4 and full-year 2025 while comparable currency-neutral operating income rose 13% for both periods; reported operating income fell 32% y/y largely due to a $960M non-cash impairment on BODYARMOR and currency headwinds. Free cash flow (excluding a contingent Fairlife payment) was $11.4B in 2025 and management forecasts ~ $12.2B FCF for 2026 (~7% y/y), with guidance of 4–5% organic revenue growth and 5–6% comparable currency-neutral EPS growth. The stock trades near ~26x P/E, yields 2.7% with a ~67% payout ratio; valuation is premium but underpinned by predictable cash flow and dividends, leaving limited margin for error.

Analysis

The core competitive edge remains the concentrate model and an ability to flex price versus mix across channels; the second-order beneficiary is the concentrate supplier base and digital price/mix analytics vendors that help pare SKU complexity. Bottlers are the asymmetric risk: if management pushes more marketing or packaging investment to defend growth, bottler margins/capex will be the first place incremental cash is absorbed, creating divergence between the concentrate equity and listed bottlers.

Currency volatility and lower-income consumer downtrading are the dominant near-term swing factors — not headline organic growth. A stronger dollar or renewed EM softness would compress reported gains even if local operations hold, and private-label/value pack penetration can accelerate share shifts within quarters. Watch the cadence of monthly volumes and bottler negotiations as 60–180 day catalysts that will either validate or reverse the current momentum.

From a valuation and capital-allocation angle, predictability is priced in; that makes the equity sensitive to multiple compression if macro risk-free rates fall or if buyback cadence disappoints. That sensitivity argues for structures that capture cash return upside while limiting downside exposure: monetization through call overwriting or collar trades is preferable to outright long exposure for short-to-intermediate horizons.

Contrarian edge: the market underestimates the possibility of further North America margin expansion from SKU rationalization and trade-promo normalization — a 12–24 month tail that could re-rate the business without incremental revenue surprises. Conversely, consensus also underprices the risk that a single material bottler misstep or FX swing could absorb a year of incremental FCF, so position sizing should reflect binary outcomes rather than steady-state forecasts.

Key Decisions for Investors

• Covered-income: Buy KO shares and sell 3-month slightly OTM calls to harvest premium and shorten the time to breakeven; target 4–6% total return in 3 months, roll if volume momentum confirms; size as 1–2% of equity book to limit single-name exposure.
• Pair trade: Long KO / Short PEP (1:1) for 6–12 months to isolate beverage concentrate execution vs snack exposure; expect outperformance if SKU mix and NA margin initiatives continue – reduce if YOY monthly volumes trend negative for two consecutive months.
• Tail-protection collar: Buy KO and simultaneously buy 9–12 month puts ~10–15% OTM while funding with nearer-term call sales to cap upside; cost-effective hedge if concerned about multiple compression while keeping dividend exposure.
• Event short via options: Purchase 6–9 month KO put spreads (sell higher strike) sized small (0.5–1% NAV) to hedge against a material EM/FX shock or an operational miss at the next two quarterly prints; capped loss equals premium paid.